Benjamin F. Edwards & Company’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $634K | Buy |
5,343
+3,998
| +297% | +$474K | 0.01% | 635 |
|
|
2024
Q1 | $144K | Sell |
1,345
-416
| -24% | -$44.5K | ﹤0.01% | 1001 |
|
|
2023
Q4 | $175K | Buy |
1,761
+258
| +17% | +$25.6K | ﹤0.01% | 912 |
|
|
2023
Q3 | $155K | Buy |
1,503
+89
| +6% | +$9.18K | 0.01% | 796 |
|
|
2023
Q2 | $172K | Buy |
1,414
+87
| +7% | +$10.6K | 0.01% | 775 |
|
|
2023
Q1 | $204K | Sell |
1,327
-968
| -42% | -$149K | 0.01% | 713 |
|
|
2022
Q4 | $412K | Buy |
2,295
+992
| +76% | +$178K | 0.02% | 516 |
|
|
2022
Q3 | $154K | Buy |
1,303
+978
| +301% | +$116K | 0.01% | 743 |
|
|
2022
Q2 | $46K | Hold |
325
| – | – | ﹤0.01% | 1059 |
|
|
2022
Q1 | $56K | Buy |
325
+168
| +107% | +$28.9K | ﹤0.01% | 995 |
|
|
2021
Q4 | $40K | Sell |
157
-6,541
| -98% | -$1.67M | ﹤0.01% | 1097 |
|
|
2021
Q3 | $2.58M | Buy |
6,698
+4,853
| +263% | +$1.87M | 0.13% | 166 |
|
|
2021
Q2 | $434K | Buy |
1,845
+884
| +92% | +$208K | 0.02% | 475 |
|
|
2021
Q1 | $126K | Sell |
961
-655
| -41% | -$85.9K | 0.01% | 787 |
|
|
2020
Q4 | $169K | Buy |
1,616
+1,416
| +708% | +$148K | 0.01% | 687 |
|
|
2020
Q3 | $14K | Buy |
200
+100
| +100% | +$7K | ﹤0.01% | 1193 |
|
|
2020
Q2 | $6K | Sell |
100
-240
| -71% | -$14.4K | ﹤0.01% | 1388 |
|
|
2020
Q1 | $10K | Buy |
+340
| New | +$10K | ﹤0.01% | 1252 |
|
|
2019
Q4 | – | Sell |
-600
| Closed | -$10K | – | 1920 |
|
|
2019
Q3 | $10K | Hold |
600
| – | – | ﹤0.01% | 1400 |
|
|
2019
Q2 | $9K | Buy |
600
+300
| +100% | +$4.5K | ﹤0.01% | 1453 |
|
|
2019
Q1 | $6K | Hold |
300
| – | – | ﹤0.01% | 1447 |
|
|
2018
Q4 | $5K | Buy |
+300
| New | +$5K | ﹤0.01% | 1456 |
|